Oct 27 (Reuters) - Albemarle Corp ( ALB ): * ALBEMARLE ANNOUNCES SALE OF A CONTROLLING STAKE IN KETJEN TO KPS CAPITAL PARTNERS * ALBEMARLE - EXPECTS $660 MILLION FROM KETJEN AND EURECAT JV SALES * ALBEMARLE - RETAINS 100% OF KETJEN'S PCS BUSINESS, INCLUDING THE PCS PLANT IN PASADENA, TEXAS * ALBEMARLE: SEPARATELY SIGNS AGREEMENT TO SELL ITS 50%...

LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION       (a) Full name of discloser: Massachusetts Financial Services Company   (b) Owner or controller of interests and short positions disclosed, if different from 1(a):...

By Johann M Cherian Oct 27 (Reuters) - Investors are increasingly favoring U.S. companies that channel capital toward AI innovation over those offering traditional shareholder payouts such as dividends and buybacks, even as the debate over soaring valuations and an AI bubble rages on. The priority for investors is long-term growth over immediate profits, recognizing that companies neglecting AI investment...

07:20 AM EDT, 10/27/2025 (MT Newswires) -- Rakovina Therapeutics ( RKVTF ) Monday said it has presented new data at an international conference on cancer therapeutics (AACR-NCI-EORTC) in Boston. The company's poster presentation highlighted promising results from its AI-driven kt-5000AI drug discovery program for Ataxia telangiectasia and Rad3-related protein serine/threonine kinase (ATR) inhibitors for cancer therapy. While multiple ATR inhibitors...